This class will detail the structure of the global pharmaceutical industry and the process of vaccine development. We will address such questions as: where does funding for vaccine research come from? Do patents and intellectual property laws encourage or inhibit innovation? What sort of regulations must be in place to reduce risk and protect the public health? For perspective, the class will look at some historical breakthroughs in vaccine development in the United States, explore what has changed in the intervening years, and examine whether our current system is suited to meet the demands of global need. Looking ahead, we will outline what steps we can take to ensure equitable access to any new vaccines that have proven safe and effective. Lastly and crucially, we will examine what about our current system of drug and vaccine development must change in order to meet the challenge of future pandemics.
Objectives: Upon completion of this course, participants should be able to:
- Describe the current structure of the global pharmaceutical industry and whether it helps or hinders equitable access to life-saving medications and vaccines
- Discuss the difference between drug distribution models that treat vaccines as commodities versus public goods and the implications of each model for the public health
Instructor: KB Burnside-Oxendine
This will be a 2-hour online class via Zoom for 2 hours of continuing education credits.
After registering at the link below, you will receive an invitation to the Zoom class via email. It is important that you respond to the invitation and register for the Zoom class prior to the day of the class. If you have any questions, please contact Valerie Gonzalez at email@example.com.